GlassScriptPhysician profile
Vikas V Shetty
NPI 1164953717
$1,224.13
in general payments reported to CMS, 2019-2025
18 companies · $1,166 in 2025
The $1,166 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $57.67 · 2025: $1,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131 · Education: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.51 |
| Education | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $230.52 | 2025 | |
| Lundbeck LLC | $222.38 | 2025 | Vyepti |
| Pfizer INC. | $170.86 | 2025 | |
| Neurelis, INC. | $146.21 | 2025 | Valtoco |
| Merz Pharmaceuticals, LLC | $88.51 | 2025 | Xeomin |
| Axsome Therapeutics, INC. | $78.89 | 2025 | Symbravo |
| Biogen, INC. | $51.61 | 2022-2025 | Leqembi |
| Abbott Laboratories | $39.48 | 2025 | Infinity |
| Globus Medical, INC. | $24.11 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $23.82 | 2025 | |
| Eisai INC. | $23.46 | 2025 | |
| Amgen INC. | $22.05 | 2025 | Uplizna |
| Vertex Pharmaceuticals Incorporated | $20.30 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $19.65 | 2025 | Fasenra |
| Tanabe Pharma America, INC. | $18.01 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $16.57 | 2025 | Austedo Xr |
| Upsher-Smith Laboratories LLC | $16.43 | 2022 | |
| Corium, LLC | $11.27 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Shetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.